Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Troxipide

Troxipide

pharmaceutical raw materials
Troxipide structure

Troxipide 

structure
  • CAS No:

    30751-05-4

  • Formula:

    C15H22N2O4

  • Chemical Name:

    Troxipide

  • Synonyms:

    Benzamide,3,4,5-trimethoxy-N-3-piperidinyl-;Benzamide,3,4,5-trimethoxy-N-3-piperidyl-;3,4,5-Trimethoxy-N-3-piperidinylbenzamide;3-(3,4,5-Trimethoxybenzamido)piperidine;KU 54;Troxipide;Aplace;(N-Piperidin-3-yl)-3,4,5-trimethoxybenzamide;99777-81-8

  • Categories:

    Active Pharmaceutical Ingredients  >  Digestive System Drugs

Description

Troxipide is a novel gastro protective agent with antiulcer, anti-inflammatory and mucus secreting properties.


Troxipide is a member of benzamides.

Troxipide Basic Attributes

294.34600

294.35

DTXSID2023725

A - Alimentary tract and metabolism

2933399090

Characteristics

68.82000

1.91390

white powder

1.18g/cm3

179-185 °C

407.5ºC at 760 mmHg

200.3ºC

1.546

Safety Information

P264, P280, P302+P352, P305+P351+P338, P321, P332+P313, P337+P313, P362

H315

|Warning|H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]|P264, P280, P302+P352, P305+P351+P338, P321, P332+P313, P337+P313, and P362|The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory.

Drug Information

3-(3,4,5-trimethoxybenzamido)piperidine

Troxipide Use and Manufacturing

Troxipide is a drug used in the treatment of gastroesophageal reflux disease. Troxipide is a novel systemic non-antisecretory gastric cytoprotective agent with anti-ulcer, anti-inflammatory and mucus secreting properties irrespective of pH of stomach or duodenum. Troxipide is currently marketed in Japan (Aplace), China (Shuqi), South Korea (Defensa), and India (Troxip). It is used for the management of gastric ulcers, and amelioration of gastric mucosal lesions in acute gastritis and acute exacerbation of chronic gastritis.

Computed Properties

Molecular Weight:294.35
XLogP3:1.2
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:5
Exact Mass:294.15795719
Monoisotopic Mass:294.15795719
Topological Polar Surface Area:68.8
Heavy Atom Count:21
Complexity:326
Undefined Atom Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Drug Function and Efficacy

It is a new type of defense factor-enhanced gastritis and gastric ulcer therapeutic agent. It has an inhibitory effect on various experimental ulcers, a therapeutic and preventive effect on experimental gastritis, and a preventive effect on acute gastric mucosal lesions. It can enhance the blood flow of the gastric mucosa and promote tissue repair. Unlike H2-receptor antagonists, it has no effect on gastric acid secretion, but enhances the defense factors of the gastric mucosa and promotes the repair of gastric ulcer sites.

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • PKU HealthCare Corp., Ltd.

    China China
    Active
  • Hanrui Pharmaceutical (Jingmen) Co., Ltd.

    China China
    Inactive

Recommended Suppliers of Troxipide

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.